Votumumab

Revision as of 20:22, 27 September 2011 by WikiBot (talk | contribs) (Protected "Votumumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Votumumab

Articles

Most recent articles on Votumumab

Most cited articles on Votumumab

Review articles on Votumumab

Articles on Votumumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Votumumab

Images of Votumumab

Photos of Votumumab

Podcasts & MP3s on Votumumab

Videos on Votumumab

Evidence Based Medicine

Cochrane Collaboration on Votumumab

Bandolier on Votumumab

TRIP on Votumumab

Clinical Trials

Ongoing Trials on Votumumab at Clinical Trials.gov

Trial results on Votumumab

Clinical Trials on Votumumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Votumumab

NICE Guidance on Votumumab

NHS PRODIGY Guidance

FDA on Votumumab

CDC on Votumumab

Books

Books on Votumumab

News

Votumumab in the news

Be alerted to news on Votumumab

News trends on Votumumab

Commentary

Blogs on Votumumab

Definitions

Definitions of Votumumab

Patient Resources / Community

Patient resources on Votumumab

Discussion groups on Votumumab

Patient Handouts on Votumumab

Directions to Hospitals Treating Votumumab

Risk calculators and risk factors for Votumumab

Healthcare Provider Resources

Symptoms of Votumumab

Causes & Risk Factors for Votumumab

Diagnostic studies for Votumumab

Treatment of Votumumab

Continuing Medical Education (CME)

CME Programs on Votumumab

International

Votumumab en Espanol

Votumumab en Francais

Business

Votumumab in the Marketplace

Patents on Votumumab

Experimental / Informatics

List of terms related to Votumumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Votumumab (marketed under the brand name HumaSPECT) is a human monoclonal antibody and which it is used to treat cancer.


Template:Humanmonoclonals Template:SIB Template:WH Template:WikiDoc Sources